S

02607

Shanghai Pharmaceuticals Holding

12.20

0.20+1.67%
Opening11:30 11/01 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE12.000/12.000
TODAY RANGE12.000-12.280
VOL1.45M
MARKET CAP45.20B
52 WEEK RANGE10.040-14.700
AVG VOL (3M)4.28M
% TURNOVER0.04%
TURNOVER17.63M
P/E (TTM)10.125
% RANGE2.33%
EPS(TTM)1.205
P/E(FORWARD)8.381
P/B0.575
BVPS21.212
DIVIDEND0.308
P/S0.153
BETA--
DIV YIELD2.52%
FREE FLOAT MKT CAP11.21B
SHARES OUTSTANDING3.70B
NEXT EARNINGS--
FREE FLOAT919.07M
LOT SIZE100
EX-DIV DATE09/17/2024
Feeds
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

S

Shanghai Pharmaceuticals Holding

02607

+1.67%
12.200

A

Amgen

04332

--

A

Asymchem Laboratories (Tianjin)

06821

+0.97%
57.000

W

Wuxi Apptec

02359

+0.10%
51.750

C

China Conch Venture Holdings

00586

+0.28%
7.240

S

Sinopharm Group

01099

+0.93%
19.520

G

Guangzhou Baiyunshan Pharmaceutical Holdings

00874

+0.22%
18.320

L

Livzon Pharmaceutical Group

01513

+2.29%
26.750

S

Shanghai Fosun Pharmaceutical (Group)

02196

+0.81%
14.920

C

China Medical System Holdings

00867

+1.03%
7.870

S

SciClone Pharmaceuticals (Holdings)

06600

0.00%
18.720

C

China Isotope & Radiation

01763

+0.71%
11.360

W

Wuxi Biologics (Cayman)

02269

+0.86%
16.480

C

China Shineway Pharmaceutical Group

02877

+1.41%
9.330

T

The United Laboratories International Holdings

03933

+0.19%
10.580

C

Consun Pharmaceutical Group

01681

+2.78%
8.500

3

3SBio

01530

+0.51%
5.860

S

Shandong Xinhua Pharmaceutical

00719

+0.34%
5.920

B

Beijing Tong Ren Tang Chinese Medicine

03613

+1.72%
8.270

C

China Resources Pharmaceutical Group

03320

+0.73%
5.540

C

CSPC Pharmaceutical Group

01093

-8.87%
5.240
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.